Loading...

Harmony Biosciences Holdings, Inc.

HRMYNASDAQ
Healthcare
Biotechnology
$37.52
$0.81(2.21%)

Harmony Biosciences Holdings, Inc. (HRMY) Stock Overview

Explore Harmony Biosciences Holdings, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 79.1/100

Key Financials

Market Cap2.2B
P/E Ratio13.69
EPS (TTM)$2.62
ROE0.24%
Fundamental Analysis

AI Price Forecasts

1 Week$35.19
1 Month$36.61
3 Months$37.94
1 Year Target$35.77

HRMY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Harmony Biosciences Holdings, Inc. (HRMY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 65.07, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $35.77.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 13.69 and a market capitalization of 2.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;